Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2026)

Rockwell Medical filings provide 8 years of Other Non Operating Income readings, the most recent being -$156000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 34.18% to -$156000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$623000.0, a 42.74% increase, with the full-year FY2025 number at -$623000.0, up 42.74% from a year prior.
  • Other Non Operating Income hit -$156000.0 in Q4 2025 for Rockwell Medical, up from -$169000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of -$135000.0 in Q3 2023 to a low of -$965000.0 in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was -$371000.0 (2022), compared with a mean of -$385850.0.
  • Biggest five-year swings in Other Non Operating Income: crashed 902.82% in 2021 and later skyrocketed 75.44% in 2024.
  • Rockwell Medical's Other Non Operating Income stood at -$582000.0 in 2021, then soared by 31.96% to -$396000.0 in 2022, then plummeted by 143.69% to -$965000.0 in 2023, then skyrocketed by 75.44% to -$237000.0 in 2024, then surged by 34.18% to -$156000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$156000.0 (Q4 2025), -$169000.0 (Q3 2025), and -$143000.0 (Q2 2025) per Business Quant data.